Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2007; 28(04): 18-22
DOI: 10.1055/s-0041-1733237
Review Article

Role of Radiotherapy in Ovarian Cancer

T Kataria
Department of Radiation Oncology, Rajiv Gandhi Cancer Institute & Research Centre, New Delhi, India
,
Shravan Kumar
Department of Radiation Oncology, Rajiv Gandhi Cancer Institute & Research Centre, New Delhi, India
› Author Affiliations
› Further Information
Also available at
 PDF Download Permissions and Reprints


Publication History

Article published online:
07 March 2022

© 2007. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Cannistra SA. Cancer of the ovary. N Engl J Med 1993;1550-9.
  • 2 Martinez A, Schray MF, Howes AE, Bagshaw MA. Postoperative radiation therapy for epithelial ovarian cancer: the curative role based on a 24-year experience. J Clin Oncol. 1985;3:901-11.
  • 3 Gronroos M, Nieminen U, Kauppila A, Kauppila O, Saksela E, Vayrynen M. A prospective, randomized, national trial for treatment of ovarian cancer: the role of chemotherapy and external irradiation. Eur J Obstet Gynecol Reprod Biol. 1984;17:33-42.
  • 4 Hreshchyshyn MM, Park RC, Blessing JA, et al. The role of adjuvant therapy in Stage I ovarian cancer. Am J Obstet Gynecol. 1980;138:139-45.
  • 5 Dembo AJ, Bush RS, Beale FA, Bean HA, Pringle JF, Sturgeon J. The Princess Margaret Hospital Study of Ovarian Cancer: Stages I, II and asymptomatic III presentations. Cancer Treat Rep. 1979;63:249-54.
  • 6 Feinstein AR, Sosin DM, Wells CK. The Will Rogers Phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312:1604-8.
  • 7 Dembo AJ, Davy S, Stenwig AE, Berle EJ, Bush RS, Kjorstad K. Prognostic factors in patients with Stage I epithelial ovarian cancer. Obstet Gynecol 1990;75:263-73.
  • 8 Piver MS, Barlow JJ, Lele SB. Incidence of subclinical metastasis in stage I and II ovarian carcinoma. Obstet Gynecol 1978;52:100-4.
  • 9 Dembo AJ, Bush RS, Beale FA, et al. A randomized clinical trial of moving strip versus open field whole abdominal irradiation in patients with invasive epithelial cancer of ovary. Int J Radiat Oncol Biol Phys 1983;9:97-102.
  • 10 Withers HR, Taylor JMG, Maciejewski B. the hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncol 1988;27:131-46.
  • 11 Dembo AJ, Bush RS, Beale FA, Bean HA, Pringle JF, Sturgeon JF. The Princess Margaret Hospital study of ovarian cancer: stage I, II and asymptomatic III presentations. Cancer Treat Rep 1979;63:249-54.
  • 12 Dietl J, Marzusch K. Ovarian surface epithelium and human ovarian cancer. Gynecol Obstet Invest 1993;35:129-35.
  • 13 Morgan L, Chafe W, Mendenhall W, Marcus R. Hyperfractionation of whole-abdomen radiation therapy: salvage treatment of persistent ovarian carcinoma following chemotherapy. Gynecol Oncol 1988;31:122-36.
  • 14 Delclos L, Smith JP. Ovarian cancer, with special regard to types of radiotherapy. NCI Monogr 1975;42:129.
  • 15 Dembo AJ, Bush RS, Brown TC. Clnicopathological correlates in ovarian cancer. Bull Cancer (Paris) 1982;69:292-97.
  • 16 Lindner H, Willich H, Atzinger A. Primary adjuvant whole abdominal irradiation in ovarian carcinoma. Int J Radiat Oncol Biol Phys 1990;19:1203-6.
  • 17 Goldberg N, Peschel RE. Postoperative abdominopelvic radiation therapy for ovarian cancer. Int J Radiat Oncol Biol Phys 1988;62:425-9.
  • 18 Sell A, Bertelsen K, Anderson JE, Stroyer I, Panduro J. Randomized study of whole abdomen irradiation versus pelvic irradiation plus cyclophosphamide in treatment of early ovarian cancer. Gynecol Oncol 1990;37:367-73.
  • 19 Schray M, Martinez A, Howes A, et al. Advanced epithelial cancer: salvage whole abdominal irradiation for patients with recurrent or persistent disease after combination chemotherapy. J Clin Oncol 1988;6:1433-9.
  • 20 Sedlak J, Hunakova L, Chorvath M, et al. Resistance of human multidrug-resistant neoplastic cell lines to paclitaxel-induced-radiosensitization is reduced by the non-immunosuppressive cyclosporine analog SDZ PSC 833. Anticancer Res. 1998;18:3099-105.
  • 21 Kong JS, Peters LJ, Wharton JT et al. Hyperfractionated split-course whole abdominal radiotherapy for ovarian carcinoma: tolerance and toxicity. Int J Radiat Oncol Biol Phys. 1988;14:737-43.
  • 22 E C, Quon M, Gallant V, Samant R. Effective palliative radiotherapy for symptomatic recurrent or residual ovarian cancer. Gynecol Oncol. 2006;102:204-9.
  • 23 Ozols RF, Schwartz PE and Eifel P.J. Ovarian Cancer, Fallopian tube carcinoma and periteneal carcinoma. In: Devita V, Hellman S, Rosenberg S. Cancer: Principles & Practice of Oncology. 5th Edition. Lippincott Williams &Wilkins. 2005.PP1605-1608